|
1
|
Geller DS and Gorlick R: Osteosarcoma: A
review of diagnosis, management, and treatment strategies. Clin Adv
Hematol Oncol. 8:705–718. 2010.PubMed/NCBI
|
|
2
|
Raymond AK and Jaffe N: Osteosarcoma
multidisciplinary approach to the management from the pathologist's
perspective. Cancer Treat Res. 152:63–84. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Ferrari S, Mercuri M, Bacci G, Bielack SS
and Jürgens H: Comment on ‘Prognostic factors in high-grade
osteosarcoma of the extremities or trunk: An analysis of 1,702
patients treated on neoadjuvant Cooperative Osteosarcoma Study
Group protocols’. J Clin Oncol. 20:2910–2911. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Broadhead ML, Clark JC, Myers DE, Dass CR
and Choong PF: The molecular pathogenesis of osteosarcoma: A
review. Sarcoma. 2011:9592482011. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
He JP, Hao Y, Wang XL, Yang XJ, Shao JF,
Guo FJ and Feng JX: Review of the molecular pathogenesis of
osteosarcoma. Asian Pac J Cancer Prev. 15:5967–5976. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Fang Z, Du R, Edwards A, Flemington EK and
Zhang K: The sequence structures of human microRNA molecules and
their implications. PLoS One. 8:e542152013. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
He L and Hannon GJ: MicroRNAs: Small RNAs
with a big role in gene regulation. Nat Rev Genet. 5:522–531. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Nicoloso MS, Spizzo R, Shimizu M, Rossi S
and Calin GA: MicroRNAs - the micro steering wheel of tumour
metastases. Nat Rev Cancer. 9:293–302. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Bartel DP: MicroRNAs: Genomics,
biogenesis, mechanism, and function. Cell. 116:281–297. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Bueno MJ, Pérez de Castro I and Malumbres
M: Control of cell proliferation pathways by microRNAs. Cell Cycle.
7:3143–3148. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Calin GA and Croce CM: MicroRNA signatures
in human cancers. Nat Rev Cancer. 6:857–866. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Saumet A and Lecellier CH: microRNAs and
personalized medicine: Evaluating their potential as cancer
biomarkers. Adv Exp Med Biol. 888:5–15. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Nugent M: microRNA and bone cancer. Adv
Exp Med Biol. 889:201–230. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Jones KB, Salah Z, Del Mare S, Galasso M,
Gaudio E, Nuovo GJ, Lovat F, LeBlanc K, Palatini J, Randall RL, et
al: miRNA signatures associate with pathogenesis and progression of
osteosarcoma. Cancer Res. 72:1865–1877. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Gougelet A, Pissaloux D, Besse A, Perez J,
Duc A, Dutour A, Blay JY and Alberti L: Micro-RNA profiles in
osteosarcoma as a predictive tool for ifosfamide response. Int J
Cancer. 129:680–690. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Pan W, Wang H, Jianwei R and Ye Z:
MicroRNA-27a promotes proliferation, migration and invasion by
targeting MAP2K4 in human osteosarcoma cells. Cell Physiol Biochem.
33:402–412. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Salah Z, Arafeh R, Maximov V, Galasso M,
Khawaled S, Abou-Sharieha S, Volinia S, Jones KB, Croce CM and
Aqeilan RI: miR-27a and miR-27a* contribute to metastatic
properties of osteosarcoma cells. Oncotarget. 6:4920–4935. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Tamura K, Kanaoka Y, Jinno S, Nagata A,
Ogiso Y, Shimizu K, Hayakawa T, Nojima H and Okayama H: Cyclin G: A
new mammalian cyclin with homology to fission yeast Cig1. Oncogene.
8:2113–2118. 1993.PubMed/NCBI
|
|
19
|
Okamoto K and Beach D: Cyclin G is a
transcriptional target of the p53 tumor suppressor protein. EMBO J.
13:4816–4822. 1994.PubMed/NCBI
|
|
20
|
Shang Y, Feng B, Zhou L, Ren G, Zhang Z,
Fan X, Sun Y, Luo G, Liang J, Wu K, et al: The
miR27b-CCNG1-P53-miR-508-5p axis regulates multidrug resistance of
gastric cancer. Oncotarget. 7:538–549. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Fornari F, Gramantieri L, Giovannini C,
Veronese A, Ferracin M, Sabbioni S, Calin GA, Grazi GL, Croce CM,
Tavolari S, et al: MiR-122/cyclin G1 interaction modulates p53
activity and affects doxorubicin sensitivity of human
hepatocarcinoma cells. Cancer Res. 69:5761–5767. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Liu X, Ma L, Rao Q, Mao Y, Xin Y, Xu H, Li
C and Wang X: MiR-1271 inhibits ovarian cancer growth by targeting
cyclin G1. Med Sci Monit. 21:3152–3158. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Huang Y, Shen XJ, Zou Q, Wang SP, Tang SM
and Zhang GZ: Biological functions of microRNAs: A review. J
Physiol Biochem. 67:129–139. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Kushlinskii NE, Fridman MV and Braga EA:
Molecular mechanisms and microRNAs in osteosarcoma pathogenesis.
Biochemistry (Mosc). 81:315–328. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Ram Kumar RM, Boro A and Fuchs B:
Involvement and clinical aspects of microRNA in osteosarcoma. Int J
Mol Sci. 17:E8772016. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Ma C, Zhan C, Yuan H, Cui Y and Zhang Z:
MicroRNA-603 functions as an oncogene by suppressing BRCC2 protein
translation in osteosarcoma. Oncol Rep. 35:3257–3264. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Zeng G, Xun W, Wei K, Yang Y and Shen H:
MicroRNA-27a-3p regulates epithelial to mesenchymal transition via
targeting YAP1 in oral squamous cell carcinoma cells. Oncol Rep.
36:1475–1482. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Morales S, Gulppi F, Gonzalez-Hormazabal
P, Fernandez-Ramires R, Bravo T, Reyes JM, Gomez F, Waugh E and
Jara L: Association of single nucleotide polymorphisms in
Pre-miR-27a, Pre-miR-196a2, Pre-miR-423, miR-608 and Pre-miR-618
with breast cancer susceptibility in a South American population.
BMC Genet. 17:1092016. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Danza K, Silvestris N, Simone G, Signorile
M, Saragoni L, Brunetti O, Monti M, Mazzotta A, De Summa S, Mangia
A, et al: Role of miR-27a, miR-181a and miR-20b in gastric cancer
hypoxia-induced chemoresistance. Cancer Biol Ther. 17:400–406.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Liu F, Dear K, Huang L, Liu L, Shi Y, Nie
S, Liu Y, Lu Y and Xiang H: Association between microRNA-27a
rs895819 polymorphism and risk of colorectal cancer: A
meta-analysis. Cancer Genet. 209:388–394. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Gao Y, Li BD and Liu YG: Effect of miR27a
on proliferation and invasion in colonic cancer cells. Asian Pac J
Cancer Prev. 14:4675–4678. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Chen DS, Zhu NL, Hung G, Skotzko MJ,
Hinton DR, Tolo V, Hall FL, Anderson WF and Gordon EM: Retroviral
vector-mediated transfer of an antisense cyclin G1 construct
inhibits osteosarcoma tumor growth in nude mice. Hum Gene Ther.
8:1667–1674. 1997. View Article : Google Scholar : PubMed/NCBI
|
